Suppr超能文献

血管内动脉瘤修复的现状:20 年的学习。

Current status of endovascular aneurysm repair: 20 years of learning.

机构信息

Division of Vascular and Endovascular Surgery, Sanger Heart and Vascular Institute, Carolinas Medical Center, 1001 Blythe Avenue, Suite 300, Charlotte, NC 28203, USA.

出版信息

Semin Vasc Surg. 2012 Sep;25(3):131-5. doi: 10.1053/j.semvascsurg.2012.08.002.

Abstract

Parodi first introduced endovascular aneurysm repair (EVAR) in 1991 and since that time it has been shown to have a lower 30-day morbididty and mortality compared to open surgery. Anatomic constraints governed by the need for adequate access vessels, and sufficient proximal and distal landing zones, as well as the need for long-term surveillance, have been the main limitations of this technology. Anatomic factors were initially estimated to exclude 40% of patients with abdominal aortic aneurysm (AAA). The rapid extension of EVAR technology has been complimented by improved access to both high-quality imaging modalities and a variety of endografts. These developments have led EVAR to become a more practical alternative for patients with ruptured AAA. Early data in this setting is encouraging with even more profound reductions in morbidity and mortality than seen in the elective repair.

摘要

1991 年,Parodi 首次引入了血管内动脉瘤修复术(EVAR),此后,与开放手术相比,它显示出更低的 30 天发病率和死亡率。需要足够的入路血管、足够的近端和远端着陆区,以及需要长期监测,这些解剖学限制一直是这项技术的主要限制。最初,解剖学因素估计会排除 40%的腹主动脉瘤(AAA)患者。EVAR 技术的快速扩展得益于高质量成像方式和各种内支架的广泛应用。这些发展使得 EVAR 成为破裂性 AAA 患者更实用的选择。这一治疗环境下的早期数据令人鼓舞,其发病率和死亡率的降低幅度甚至超过了择期修复。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验